The journal aims to provide full-length/mini review articles as well as research papers on new bioactive compounds with proven activities in various biological screenings and pharmacological models with a special emphasis on stereoeselective synthesis. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia.
The journal should prove to be essential reading for pharmacologists, natural product chemists and medicinal chemists who wish to be kept informed and up-to-date with the most important developments on new bioactive compounds of natural or synthetic origin, including their stereoeselective synthesis.
Abdul-Malik Abudunia, Ilias Marmouzi*, Mourad Kharbach, Meryem El Jemli, Karima Sayah, Abdelhakim Bouyahya, Ali Al-kaf, Ali Alyahawi, M’Hammed Ansar, Abdelaziz Bouklouze, My El Abbes Faouzi and Azeddine Ibrahimi
Adriano Mollica Department of Pharmacy, University ”G. d' Annunzio” of Chieti-Pescara Via dei Vestini 31 Chieti, 66100 (Italy) Biography
Biography of Adriano Mollica
Dr. Adriano Mollica is Associate Professor of Medicinal Chemistry at the Univ. “G. d’ Annunzio” of Chieti-Pescara, Italy and PhD in “Pharmaceutical Sciences”. From 2013 he is Member of the Board of PhD program “Biomol. and Pharm. Sciences” and Tutor of several PhD students and Post-doctoral fellows. His research interests are focused on opioid peptides, neurodegeneration, treatment of chronic and neuropathic pain, multi-target compounds and nutraceuticals. He is co-author of 82 papers published in international journals, one European Patent and one Italian Patent. He is currently “Editor in Chief” of “Current Bioactive Compounds”, and Editorial Board Member of Mini rev. in Org. Chem. and of Prot. & Pept. Lett.